#hepatitis

World Hepatitis Day aims to eliminate viral hepatitis by 2030 by spreading awareness and combating stigma surrounding the disease.

Watch groundbreaking scientists share their experiences and explain how Damon Runyon funding makes a difference in cancer research.

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.

Since 1991, most children have been getting vaccinated against hepatitis B, so most adults under 30 are not at risk for the liver disease.

Barriers still stand in the way of making treatment available to all who need it.

The Supreme Court upholds the Affordable Care Act for a third time. Here’s a look at responses from health care advocates.

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.

290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.

People who have more flu, pneumonia, gastroenteritis, and hepatitis infections are more likely to be diagnosed with cancer.

New research shows that treating these viruses can reduce liver cancer risk.

A new study appears to resolve controversy over hep C treatment’s association with mortality risk.

Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.

Four things you should know to be #HepAware.

Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.